SHC: Solid Q3 growth and lower leverage support reaffirmed FY guidance; Nordion faced harvest-timing pressure

What happened

Sotera Health reported third-quarter revenue growth of 4.4%, Adjusted EBITDA growth of 3.9% and a 12% rise in Adjusted EPS. The company reaffirmed its guidance, and leverage improved to 2.9x, which means borrowed money fell relative to earnings. Nordion's quarterly sales were pressured by Co-60 harvest timing.

Confirmed

Global impact / market context

Falling leverage means the company owes less borrowed money relative to its earnings, which can lower interest costs and free up cash for capital spending or debt repayment. Reaffirmed guidance signals management expects results to stay on track despite Nordion's harvest-timing sales pressure.

Analyst inference

Investors weigh steady revenue and profit growth against a weak spot at Nordion, where Co-60 harvest timing pushed sales into a different period rather than removing demand. Improved leverage, meaning borrowed money relative to earnings, at 2.9x supports confidence in the balance sheet while guidance stays unchanged.

Analyst inference

What to watch

1. Watch whether Nordion's Co-60 sales recover in later quarters, since harvest timing shifted revenue between periods rather than necessarily reducing total demand. Confirmed
2. Track whether management provides more detail on the timing of Co-60 harvests and any effect on Nordion's full-year sales outlook. Proposed
3. Monitor whether leverage, meaning borrowed money relative to earnings, stays near 2.9x, because further improvement could lower interest costs and support capital spending or debt reduction. Analyst inference

Evidence

• Original source link unavailable